Citadel Advisors
IGC icon

Citadel Advisors’s IGC Pharma IGC Stock Holding History

Citadel Advisors’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-600
Closed -$202 – 14979
2024
Q4 		$202 Sell
600
-600
-50% -$225 ﹤0.01% 14368
2024
Q3 		$512 Buy
1,200
+400
+50% +$160 ﹤0.01% 14005
2024
Q2 		$347 Buy
+800
New +$398 ﹤0.01% 14016
2024
Q1 		– Sell
-2,600
Closed -$728 – 14982
2023
Q4 		$728 Hold
2,600
– – ﹤0.01% 13951
2023
Q3 		$934 Buy
2,600
+100
+4% +$36 ﹤0.01% 13951
2023
Q2 		$779 Hold
2,500
– – ﹤0.01% 14048
2023
Q1 		$849 Sell
2,500
-24,900
-91% -$9.34K ﹤0.01% 14409
2022
Q4 		$8.72K Sell
27,400
-500
-2% -$204 ﹤0.01% 13734
2022
Q3 		$12K Buy
27,900
+700
+3% +$373 ﹤0.01% 12226
2022
Q2 		$14K Sell
27,200
-8,000
-23% -$5.05K ﹤0.01% 12512
2022
Q1 		$33K Sell
35,200
-19,700
-36% -$19.1K ﹤0.01% 13052
2021
Q4 		$54K Sell
54,900
-24,600
-31% -$33K ﹤0.01% 13208
2021
Q3 		$118K Buy
79,500
+9,300
+13% +$15K ﹤0.01% 12664
2021
Q2 		$115K Sell
70,200
-12,900
-16% -$19.7K ﹤0.01% 12787
2021
Q1 		$149K Buy
83,100
+41,400
+99% +$75.2K ﹤0.01% 12040
2020
Q4 		$65K Buy
41,700
+26,500
+174% +$39.2K ﹤0.01% 10461
2020
Q3 		$16K Buy
+15,200
New +$15.4K ﹤0.01% 9895

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citadel Advisors's IGC Position: Q2 2026 in Review

Citadel Advisors opened a new position in IGC Pharma (IGC) in Q2 2026: 437,317 shares worth $119K. The stake represents ﹤0.01% of the portfolio and ranks #12544 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in IGC as recently as Q4 2025.

Citadel Advisors first reported a position in IGC in Q4 2013 and has held it in 31 quarters since. The position peaked at $262K in Q3 2025. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Citadel Advisors held 437,317 shares of IGC Pharma worth $119K as of Q2 2026.
  • IGC Pharma was a new Citadel Advisors position in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #12544 holding.
  • Citadel Advisors first reported a position in IGC Pharma in Q4 2013 and has held it in 31 quarters since.
  • Citadel Advisors's IGC Pharma position peaked at $262K in Q3 2025.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.